Source: OncLive, March 2019 Antoni Ribas, MD, PhD, professor of medicine, University of California, Los Angeles, director, Tumor Immunology Program, Jonsson Comprehensive Cancer Center, discusses immune-related adverse events (irAEs) in melanoma. With immune checkpoint inhibition, physicians have to be aware of the potential irAEs, which may include autoimmune reactions or inflammatory toxicities, says Ribas. Over […]
Posted in Melanoma News, Health Professionals, Video Reports
Source: OncLive, March 2019 Hussein A. Tawbi, MD, PhD, associate professor, The University of Texas MD Anderson Cancer Center, discusses unmet needs in melanoma. There are many unmet needs in melanoma, one of which includes improving the cure rate with the least toxicity. Combination therapies are often used over the course of a patient’s treatment […]
Posted in Melanoma News, Health Professionals, Video Reports
Source: Johns Hopkins Medicine, March 2019 Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University School of Medicine report two new forms of an older anti-cancer agent they developed appear to enhance the immune system’s ability to fight melanoma in mice. The agents, dubbed s-DAB-IL-2 and s-DAB-IL-2(V6A), comprise a regulatory protein […]
Posted in Melanoma News, Health Professionals, Of Interest
Source: The Daily Free Press, March 2019 Although melanoma — a type of skin cancer — is expected to claim 7,230 lives this year, according to the American Cancer Society, new hope for treating the disease is in the works at Boston University. The number of melanoma victims may decrease in the coming years with the […]
Posted in Melanoma News, Health Professionals, Of Interest
